# ROLE OF PROPHYLACTIC TRANEXAMIC ACID IN PREVENTION OF POST-PARTUM HEMORRHAGE IN ELLSCS

> **NCT07002749** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Patel Hospital, Pakistan** · enrollment: 104 (estimated)

## Conditions studied

- Post Partum Hemorrhage

## Interventions

- **DRUG:** Tranexamic Acid (TXA)
- **DEVICE:** Placebo

## Key facts

- **NCT ID:** NCT07002749
- **Lead sponsor:** Patel Hospital, Pakistan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-12-31
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07002749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07002749, "ROLE OF PROPHYLACTIC TRANEXAMIC ACID IN PREVENTION OF POST-PARTUM HEMORRHAGE IN ELLSCS". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07002749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*